Methylprednisolone Sodium Succinate

   
Google
 
Web NewDrugInformation.com

Methylprednisolone Sodium Succinate


Drug - Methylprednisolone Sodium Succinate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methylprednisolone Sodium Succinate
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE/VIAL
The potency of the active ingredient(s), Methylprednisolone Sodium Succinate. May repeat for multiple part products.

Applicant - SICOR PHARMS
The firm name holding legal responsibility for Methylprednisolone Sodium Succinate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 081267
The FDA assigned number to Methylprednisolone Sodium Succinate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Methylprednisolone Sodium Succinate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 30, 1992
The date Methylprednisolone Sodium Succinate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Methylprednisolone Sodium Succinate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Methylprednisolone Sodium Succinate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sicor Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Methylprednisolone Sodium Succinate.

Methylprednisolone Sodium Succinate